https://i1.wp.com/gramener.com/wp-content/uploads/2018/05/Donald_Trump.jpg?fit=1200%2C1520&ssl=1 1520 1200 Ganes Kesari https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Ganes Kesari2018-06-02 14:00:272018-07-06 16:28:48What is in the mind of Donald Trump?
Love him or hate him, Donald Trump is a force to reckon with. He is not only among the most powerful world leaders but also among the most popular. He is known to be to speak his mind instantly on Twitter. So will his tweets have a clue to what…
https://i2.wp.com/gramener.com/wp-content/uploads/2018/07/world-1185076.png?fit=1920%2C1080&ssl=1 1080 1920 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-30 12:07:502018-07-30 12:30:465 ways digital pharmaceutical marketing can catalyze the sales
The pharma companies are increasing their sales records coming to terms with digital technology. Hence, pharmaceutical marketing is booming the sales of the businesses, making the drug manufacturing companies recognized brands.
https://i0.wp.com/gramener.com/wp-content/uploads/2018/07/drugs-3541680_1280.jpg?fit=1280%2C720&ssl=1 720 1280 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-25 23:58:142018-07-31 18:30:21Drug Discovery research made effortless by data-relational model
By joining hands with market leading CROs, Gramener develops a visual data relational model and matrix to augment the drug discovery for diseases, majorly cancer.
https://i1.wp.com/gramener.com/wp-content/uploads/2018/07/34863371-charity-word-cloud-concept-vector-illustration.jpg?fit=1300%2C613&ssl=1 613 1300 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-25 05:15:512018-07-26 11:18:57How Data Science Can Help NGOs Prioritize Their Investments
It is important for the NGOs to keep a track of the investments for medical researches. We help NGOs and Pharma to get a direction of investment by presenting their yearly data in visuals. Read on to know more.
https://i0.wp.com/gramener.com/wp-content/uploads/2018/07/clinical-trial-icon-2793430.png?fit=1920%2C1920&ssl=1 1920 1920 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-23 07:24:262018-07-31 18:43:03Adverse event reporting system: A blessing in disguise for clinical trials
The adverse drug reaction has increased so much that the clinical trials before drug manufacturing needs to be more precise. Read how our data visualizations can help pharma companies to understand the seriousness of the reported cases.
https://i0.wp.com/gramener.com/wp-content/uploads/2018/07/generic-image-3-01-1024x768.jpg?fit=1024%2C768&ssl=1 768 1024 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-20 08:55:502018-07-26 11:23:32Data Visualizations: Interesting Insights on Adverse Drug Reports
Know which age groups are more susceptible to the adverse drug reactions and why is it so. Our data visualizations depict the manufacturer wise information about the adverse event cases reported yearly.
https://i2.wp.com/gramener.com/wp-content/uploads/2018/07/Faer.png?fit=500%2C300&ssl=1 300 500 Sunil Sharma https://gramener.com/wp-content/uploads/2018/07/gramener-logo-340X156-blue.png Sunil Sharma2018-07-19 10:24:442018-07-26 11:29:53Data Visualizations Empowering FDA Adverse Event Reporting System
The Food and Drug Administration (FDA) release their adverse event reporting system data quarterly. Converting the data into visualizations, Gramener highlights interesting insights for pharma companies to notice. Read more...